HeadInvest LLC’s GE HealthCare GEHC Stock Holding History

HeadInvest LLC’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,317	Closed	-$89.3K	–	394
2023 Q3	$89.3K	Buy	+1,317	New	+$95.8K	0.02%	292

Other funds holding GEHC

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

HeadInvest LLC's GEHC Position: Q4 2023 in Review

HeadInvest LLC sold out of GE HealthCare (GEHC) in Q4 2023, closing a stake of 1,317 shares — an estimated $89.3K sold.

HeadInvest LLC first reported a position in GEHC in Q3 2023 and held it in 1 quarter. The position peaked at $89.3K in Q3 2023. 1,186 funds tracked by Wall St. Rank hold GEHC as of Q4 2023.

HeadInvest LLC reported no remaining GE HealthCare position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 1,317 GE HealthCare shares in Q4 2023, an estimated $89.3K.
HeadInvest LLC first reported a position in GE HealthCare in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's GE HealthCare position peaked at $89.3K in Q3 2023.
1,186 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.